We searched the databases PubMed and EMBASE (Jan 1, 2000, to May 1, 2005) using the following keywords: “phaeochromocytoma”, “paraganglioma”, and “extra-adrenal”. We also included review articles, book chapters, or commonly referenced older publications. We reviewed the reference lists of articles identified by the search strategy and selected those we judged relevant. The search was restricted to papers published in English.
SeminarPhaeochromocytoma
Section snippets
Genetics of phaeochromocytoma
Advances in genetics and recognition of the high prevalence of phaeochromocytoma in certain familial syndromes led to mandatory routine screening in patients with identified mutations, even in the absence of typical clinical signs and symptoms.40 Accumulating evidence also suggests that a hereditary basis for phaeochromocytoma is more frequent than previously thought, accounting for up to 24% of patients with the tumour with no obvious initial evidence of a syndrome or family history.13, 24, 41
Biochemical testing
All patients with suspected phaeochromocytoma should undergo biochemical testing. These include patients with paroxysmal signs or symptoms suggestive of a phaeochromocytoma; patients with recent, therapy-resistant, or volatile hypertension; patients with a paradoxical blood pressure response during surgery and anaesthesia; patients with a hereditary predisposition for a phaeochromocytoma; asymptomatic patients with an adrenal incidentaloma; and patients with sudden attacks of anxiety. Because
Preoperative management
Once a phaeochromocytoma is located, complications during surgery need to be kept to a minimum by appropriate preoperative medical treatment. With adequate pretreatment, perioperative mortality has fallen to less than 3%, which emphasises the importance for adequate preoperative management.12, 88, 89 The major aim of medical pretreatment is to prevent catecholamine-induced, serious, and potentially life-threatening complications during surgery, including hypertensive crises, cardiac
Search strategy and selection criteria
References (133)
- et al.
Extra-adrenal pheochromocytoma
J Urol
(1992) - et al.
Adrenal pheochromocytoma remains a frequently overlooked diagnosis
Am J Surg
(2000) - et al.
Mortality associated with pheochromocytoma in a large Swedish cohort
Eur J Surg Oncol
(2004) - et al.
Pheochromocytoma. Update on diagnosis, localization, and management
Med Clin North Am
(1995) - et al.
Benign and malignant pheochromocytoma: diagnosis, treatment, and follow-Up
Surg Oncol Clin N Am
(1998) Pheochromocytoma presenting as shock
Am J Emerg Med
(1989)- et al.
Cardiovascular manifestations of pheochromocytoma
Am J Emerg Med
(2000) - et al.
Diagnostic evaluation of pheochromocytoma
Endocrinol Metab Clin North Am
(1988) - et al.
Clinical and genetic characterization of pheochromocytoma in von Hippel-Lindau families: comparison with sporadic pheochromocytoma gives insight into natural history of pheochromocytoma
J Urol
(1999) - et al.
von Hippel-Lindau disease
Lancet
(2003)
Gene mutations in the succinate dehydrogenase subunit SDHB cause susceptibility to familial pheochromocytoma and to familial paraganglioma
Am J Hum Genet
Sensitivity and specificity of a new ELISA method for determination of chromogranin A in the diagnosis of pheochromocytoma and neuroblastoma
Clin Chim Acta
Is preoperative iodine 123 meta-iodobenzylguanidine scintigraphy routinely necessary before initial adrenalectomy for pheochromocytoma?
Surgery
Anesthesia for patients with pheochromocytoma
Anesthesiol Clin North Am
Perioperative management of pheochromocytoma
J Cardiothorac Vasc Anesth
Effects of perioperative alpha1 block on haemodynamic control during laparoscopic surgery for phaeochromocytoma
Br J Anaesth
Phaeochromocytoma—recent progress in its management
Br J Anaesth
Successful outcomes in pheochromocytoma surgery in the modern era
J Urol
Recent advances in genetics, diagnosis, localization, and treatment of pheochromocytoma
Ann Intern Med
Benign paragangliomas: clinical presentation and treatment outcomes in 236 patients
J Clin Endocrinol Metab
The natural history of the chromaffin cell
The effect of age on prevalence of secondary forms of hypertension in 4429 consecutively referred patients
J Hypertens
Prospective study on the prevalence of secondary hypertension among hypertensive patients visiting a general outpatient clinic in Japan
Hypertens Res
Secondary hypertension in a blood pressure clinic
Arch Intern Med
Death from phaeochromocytoma: lessons from a post-mortem survey
J R Coll Physicians Lond
Phaeochromocytomas discovered during coronial autopsies in Sydney, Melbourne and Auckland
Aust N Z J Med
Factors associated with perioperative morbidity and mortality in patients with pheochromocytoma: analysis of 165 operations at a single center
J Clin Endocrinol Metab
Germ-line mutations in nonsyndromic pheochromocytoma
N Engl J Med
The pressure rises: update on the genetics of phaeochromocytoma
Hum Mol Genet
Clinical spectrum and outcome of functional extraadrenal paraganglioma
World J Surg
Pheochromocytomas, multiple endocrine neoplasia type 2, and von Hippel-Lindau disease
N Engl J Med
Clinical and experimental pheochromocytoma. seconded
Pheochromocytoma in Italy: a multicentric retrospective study
Eur J Endocrinol
Pheochromocytoma: state-of-the-art and future prospects
Endocr Rev
Diabetes as a marker of pheochromocytoma in hypertensive patients
J Hypertens
A survey on adrenal incidentaloma in Italy. Study Group on Adrenal Tumors of the Italian Society of Endocrinology
J Clin Endocrinol Metab
Pheochromocytoma: the expanding genetic differential diagnosis
J Natl Cancer Inst
Circumstances of discovery of phaeochromocytoma: a retrospective study of 41 consecutive patients
Eur J Endocrinol
The clinically inapparent adrenal mass: update in diagnosis and management
Endocr Rev
Year of diagnosis, features at presentation, and risk of recurrence in patients with pheochromocytoma or secreting paraganglioma
J Clin Endocrinol Metab
Biochemical and clinical manifestations of dopamine-producing paragangliomas: utility of plasma methoxytyramine
J Clin Endocrinol Metab
Dopamine-secreting pheochromocytoma: an unrecognized entity? Classification of pheochromocytomas according to their type of secretion
Surgery
Epinephrine-secreting pheochromocytoma presenting with cardiogenic shock and profound hypocalcemia
Ann Intern Med
Cardiological effects of catecholamine-secreting tumors
Eur J Clin Invest
Pheochromocytoma as an endocrine emergency
Rev Endocr Metab Disord
Pheochromocytoma. Progress in diagnosis, treatment and genetics
[Screening for phaeochromocytoma in which hypertensive patients? A semiological study of 2585 patients, including 11 with phaeochromocytoma (author's trans)]
Nouv Presse Med
The clinical presentation (symptoms and signs) of sporadic and familial chromaffin cell tumours (phaeochromocytomas and paragangliomas)
Front Horm Res
The management of benign and malignant pheochromocytoma and abdominal paraganglioma
Eur J Surg Oncol
Guidelines for diagnosis and therapy of MEN type 1 and type 2
J Clin Endocrinol Metab
Cited by (1416)
Robot-assisted versus laparoscopic pheochromocytoma resection and construction of a nomogram to predict perioperative hemodynamic instability
2024, European Journal of Surgical OncologyNaphazoline intoxication managed with minimally invasive cardiac output monitoring
2024, American Journal of Emergency MedicineCatecholamine-induced hypertensive crises: current insights and management
2023, The Lancet Diabetes and Endocrinology